Obesity, inflammation, and insulin resistance
- PMID: 17498510
- DOI: 10.1053/j.gastro.2007.03.059
Obesity, inflammation, and insulin resistance
Abstract
Weight gain and obesity are major risk factors for conditions and diseases ranging from insulin resistance and type 2 diabetes mellitus to atherosclerosis and the sequelae of nonalcoholic fatty liver disease. A chronic, subacute state of inflammation often accompanies the accumulation of excess lipid in adipose tissue and liver (hepatic steatosis), evidenced by changes in both inflammatory cells and biochemical markers of inflammation. These changes can be seen in the involved tissues and systemically, in terms of elevated circulating levels of inflammatory markers. The link between obesity and inflammation has therefore raised the important question of whether obesity-induced inflammation plays a pathogenic role in the development and progression of these disorders. We review the rapidly expanding body of animal and clinical data that support potential roles for inflammation in the pathogenesis of insulin resistance and type 2 diabetes mellitus.
Similar articles
-
Monocyte chemotactic protein-1 and its role in insulin resistance.Curr Opin Lipidol. 2007 Jun;18(3):258-62. doi: 10.1097/MOL.0b013e3281338546. Curr Opin Lipidol. 2007. PMID: 17495598 Review.
-
The dysregulated adipose tissue: a connecting link between insulin resistance, type 2 diabetes mellitus and atherosclerosis.Nutr Metab Cardiovasc Dis. 2006 Mar;16 Suppl 1:S35-8. doi: 10.1016/j.numecd.2005.10.016. Epub 2006 Feb 9. Nutr Metab Cardiovasc Dis. 2006. PMID: 16530128 Review.
-
Mechanisms of obesity-associated insulin resistance: many choices on the menu.Genes Dev. 2007 Jun 15;21(12):1443-55. doi: 10.1101/gad.1550907. Genes Dev. 2007. PMID: 17575046 Review.
-
Obesity, inflammation, and insulin resistance--a mini-review.Gerontology. 2009;55(4):379-86. doi: 10.1159/000212758. Epub 2009 Apr 8. Gerontology. 2009. PMID: 19365105 Review.
-
Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.Gastroenterology. 2012 Apr;142(4):711-725.e6. doi: 10.1053/j.gastro.2012.02.003. Epub 2012 Feb 8. Gastroenterology. 2012. PMID: 22326434 Review.
Cited by
-
Gut microbiota promoting propionic acid production accompanies caloric restriction-induced intentional weight loss in cats.Sci Rep. 2024 May 24;14(1):11901. doi: 10.1038/s41598-024-62243-4. Sci Rep. 2024. PMID: 38789518 Free PMC article.
-
Anthrometric dimensions and their impact on cardiovascular risk factors.Medicine (Baltimore). 2024 May 24;103(21):e38140. doi: 10.1097/MD.0000000000038140. Medicine (Baltimore). 2024. PMID: 38788016 Free PMC article.
-
Effect of weight loss program using prebiotics and probiotics on body composition, physique, and metabolic products: longitudinal intervention study.Sci Rep. 2024 May 14;14(1):10960. doi: 10.1038/s41598-024-61130-2. Sci Rep. 2024. PMID: 38744950 Free PMC article.
-
Coffee consumption might be associated with lower potential risk and severity of metabolic syndrome: national health and nutrition examination survey 2003-2018.Eur J Nutr. 2024 May 4. doi: 10.1007/s00394-024-03367-1. Online ahead of print. Eur J Nutr. 2024. PMID: 38703226
-
Molecular and pathophysiological relationship between obesity and chronic inflammation in the manifestation of metabolic dysfunctions and their inflammation‑mediating treatment options (Review).Mol Med Rep. 2024 Jun;29(6):95. doi: 10.3892/mmr.2024.13219. Epub 2024 Apr 12. Mol Med Rep. 2024. PMID: 38606791 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical